RHEUMATOLOGY
Expert Insight View All

Evaluation of cancer risks in IIM: A Hong Kong perspective on IMACS stratification

Idiopathic inflammatory myopathies (IIM) is a group of autoimmune disorders characterized by chronic muscle inflammation, presenting with varying clinical features, treatment responses, and prognoses.1 Recently, the International Myositis Assessment and Clinical Studies Group (IMACS) released a set

30 Oct 2024
thumb

Dr. So, Ho

Assistant Professor,
Division of Rheumatology,
Department of Medicine and Therapeutics,
Faculty of Medicine,
The Chinese University of Hong Kong

thumb

Dr. Tang, Yan-Ki Iris

Clinical Assistant Professor of Practice, 
Department of Medicine, 
Li Ka Shing Faculty of Medicine, 
The University of Hong Kong 

Meeting Highlight View All

Shaping romosozumab treatment for postmenopausal osteoporosis: Balancing the fracture benefit and cardiovascular risk

05 May 2021
thumb

Professor Gaetano De Ferrari

Full Professor of Cardiology,
University of Torino,
Head of Cardiology, Città della Salute,
Torino, Italy